Selective thrombolytic therapy with a tissue activator of plasminogen
Carreras, L.O.
Medicina 45(3): 309-311
1985
ISSN/ISBN: 0025-7680 PMID: 3939429 Document Number: 243298
Document emailed within 1 workday
Related Documents
Wu, J.-d.; Guan, H.; Wang, S.-h.; Liu, C.-w.; Jin, Y.-f.; Liu, B.; Ye, W.; Zeng, R. 2005: Acute deep vein thrombosis of lower limbs treated by thrombolytic therapy with recombinant tissue-type plasminogen activator Zhonghua Yi Xue Za Zhi 85(7): 491-492Crabbe, S.J.; Cloninger, C.C. 1987: Tissue plasminogen activator: a new thrombolytic agent Clinical Pharmacy 6(5): 373-386
Verstraete, M.; Collen, D. 1985: Tissue plasminogen activator: a new thrombolytic specific t fibrin Nouvelle Revue Francaise d'Hematologie 27(1): 3-4
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60
Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Topol, E.J. 1989: Recombinant tissue plasminogen activator: implications in therapy Seminars in Hematology 26(3 Suppl 3: 25-31
Zoja, C.; Corna, D.; Macconi, D.; Zilio, P.; Bertani, T.; Remuzzi, G. 1990: Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis Laboratory Investigation; A Journal of Technical Methods and Pathology 62(1): 34-40
Rość, D.; Drewniak, W.; Kotschy, M.; Graczykowska-Koczorowska, A.; Raukuć, D. 1997: Plasminogen tissue activator and plasminogen tissue inhibitor in type Ii diabetes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2(7): 24-25
Krolick, M.A.; Cintron, G.B. 1991: Spinal epidural hematoma causing cord compression after tissue plasminogen activator and heparin therapy Southern Medical Journal 84(5): 670-671
Ardashev, V.N.; Sokolianskiĭ, N.V.; Bystrov, V.V. 2000: Fibrinolytic therapy of patients with pulmonary artery thromboembolism by tissue plasminogen activator and streptokinase preparations Klinicheskaia Meditsina 78(12): 28-30
Runge, M.S.; Harker, L.A.; Bode, C.; Ruef, J.; Kelly, A.B.; Marzec, U.M.; Allen, E.; Caban, R.; Shaw, S.Y.; Haber, E.; Hanson, S.R. 1996: Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons Circulation 94(6): 1412-1422
Glas-Greenwalt, P.; Hall, J.M.; Panke, T.W.; Kant, K.S.; Allen, C.M.; Pollak, V.E. 1986: Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura Journal of Laboratory and Clinical Medicine 108(5): 415-422